U.S. market Closed. Opens in 7 hours 44 minutes

PROF | Profound Medical Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue7.33M6.68M6.87M7.30M4.23M1.91M3.90MN/AN/AN/A
Cost of Revenue2.87M3.66M3.92M3.83M1.81M1.31M2.41MN/AN/AN/A
Gross Profit4.46M3.02M2.95M3.47M2.42M604.82K1.49MN/AN/AN/A
Operating Expenses33.60M32.62M33.24M22.34M17.56M15.43M15.51M11.64M8.09M4.34M
Selling, General & Admin18.96M17.93M17.97M12.43M8.01M7.89M7.84M4.20M4.39M1.95M
Research & Development14.64M14.69M15.28M9.91M9.54M7.54M7.66M7.43M3.70M2.31M
Other Operating ExpensesN/AN/AN/AN/AN/A3.75K3.65K1.57K082.40K
Operating Income-29.14M-29.60M-30.29M-18.86M-15.13M-14.83M-17.63M-11.64M-8.09M-4.34M
Other Expenses / Income-82.49K1.22M-303.00K-2.71M-176.29K152.45K2.72M-498.62K-4.24M-3.60M
Before Tax Income-29.22M-28.38M-30.59M-21.58M-15.31M-15.07M-14.91M-12.14M-12.32M-7.94M
Income Tax Expenses-130.35K287.00K105.00K45.00K148.42K169.44K58.94K10.46K-523.22KN/A
Net Income-29.09M-28.67M-30.70M-21.62M-15.46M-15.24M-14.97M-12.15M-11.80M-8.20M
Interest Expenses932.80K174.00K303.00K543.00K544.75K755.37K1.07M615.87K4.05M143.01K
Basic Shares Outstanding21.18M20.83M20.46M17.29M11.10M10.04M6.14M4.15M2.37M216.68K
Diluted Shares Outstanding21.18M20.83M20.46M17.29M11.10M10.04M6.14M4.15M2.37M216.68K
EBITDA-27.97M-25.47M-28.41M-16.63M-13.22M-13.24M-13.14M-11.38M-9.39M-6.18M
EBITDA Margin-381.58%-381.29%-413.39%-227.72%-312.49%-693.11%-337.00%0.00%0.00%0.00%
EBIT-28.29M-28.21M-30.29M-21.03M-14.76M-14.32M-13.84M-11.52M-8.27M-8.06M
EBIT Margin-385.90%-422.21%-440.72%-287.98%-348.92%-749.47%-354.78%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙